Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - April, 2004
43 articles
- E.U. Court Favors Generic Makers With Ruling Against Novartis
- Dr. Reddy's Drops Patent Challenge To Glaxo's Zofran
- Glaxo, Eon Settle Wellbutrin Patent Dispute
- Appeals Court Affirms Pfizer Marketing Exclusivity For Diflucan
- Bristol-Myers Squibb, Teva Settle Litigation Over Paraplatin
- Federal Circuit Rules For Apotex In Paxil Patent Suit
- Israel, Under Pressure From Generics Industry, Delays Changes To Patent Law
- Delaware District Court Judge Upholds Decision Favoring Atrium Medical In Patent Suit
- Judge Dismisses MedImmune's Patent Suit Vs. Genentech
- Germany Delays List Of Patented Drugs Targeted For Price Controls
- Hale and Dorr, Wilmer Cutler See Seamless Integration Of IP Groups
- Canada Strips Patent Holder Rights In Amended Drug Export Bill
- U.S. Senators Unveil Bipartisan Drug Import Bill
- Israel Expected To OK 5-Year Drug Marketing Exclusivity
- Sankyo Sues Nissin Over Mevalotin Patent
- Judge Lifts Restraining Order On AstraZeneca Generic In Philippines
- Spanish Court Deals Blow To Merck In Zocor Patent Suit
- U.S. Supreme Court Rejects Materna Case
- National Research Council Urges Patent Reforms
- Akzo Pays $28M To Settle Remeron Suits
- Abbott Unit Sues Hershey Over Low-Carb Trademark
- Dr. Reddy's Files Manufacturing Application For AstraZeneca's Seroquel
- U.S. To Put Israel On IP Priority Watch List, Newspaper Claims
- FTC Conference On Patent Reform Draws Top Decision Makers
- Apotex Appeals Abbott Depakote Ruling
- Viagra Patent Remains In Limbo In China
- Indian Drug Companies Urge Government To Pass Data Exclusivity Law
- Ranbaxy Demands Website Stop Selling Lipitor Generic In U.S.
- Poland To Seek Exemption From E.U. Data Protection Scheme
- Pfizer Sues Online Vendor For Selling Generic Lipitor
- Collagenex, Mutual Settle Patent Suit Over Periodontitis Treatment
- Sandoz Lawsuit Vs. European Commission Highlights Uncertainties Over Biogenerics
- New Jersey District Court Rules For Ranbaxy In Glaxo Patent Suit
- Federal Circuit Upholds Genentech Victory Vs. Chiron
- U.N., Clinton Foundation Expands Plan For Anti-HIV Generics
- AstraZeneca Sues Eon Labs Over Toprol-XL Patent
- FTC Backs Teva In Zoloft Patent Suit
- Diomed Sues Total Vein Solutions Over Laser Treatments
- Altana To Sue Generics Maker Over Protonix ANDA
- European Patent Office Declares Medinol Patent Invalid
- Israel To Make Concessions To U.S. On Pharma IPR
- BioGentech Agrees To Name Change As Part of Trademark Settlement
- Kos Pharma Sues Barr Over Plans To Make Cholesterol Generics